Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease. [electronic resource]
Producer: 19920107Description: 203-13 p. digitalISSN:- 0936-3076
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine -- pharmacology
- Analysis of Variance
- Animals
- Callithrix
- Disease Models, Animal
- Drug Synergism
- Ibotenic Acid -- analogs & derivatives
- Levodopa -- pharmacology
- Male
- Motor Activity -- drug effects
- Oxidopamine -- pharmacology
- Parkinson Disease, Secondary -- drug therapy
- Piperazines -- pharmacology
- Quinoxalines -- pharmacology
- Rats
- Rats, Inbred Strains
- Receptors, N-Methyl-D-Aspartate -- antagonists & inhibitors
- Substantia Nigra -- drug effects
- alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.